News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

e-Therapeutics plc' Phase I Clinical Trials of Cancer Drug ETS2101 Approved by Regulators


3/29/2012 7:38:32 AM

OXFORD & NEWCASTLE--(BUSINESS WIRE)--e-Therapeutics plc (AIM:ETX) announces that regulatory agencies in the UK and the US have approved plans for phase I trials of the Company’s anti-cancer drug ETS2101 and that enrolment of patients into trials in these two countries will begin shortly.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES